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SmvA is an important efflux 
pump for cationic biocides in 
Klebsiella pneumoniae and other 
Enterobacteriaceae
Matthew E. Wand  1, Shirin Jamshidi2, Lucy J. Bock1, Khondaker Miraz Rahman  2 & 
J. Mark Sutton1
The multidrug resistant (MDR) opportunistic pathogen Klebsiella pneumoniae has previously been 
shown to adapt to chlorhexidine by increasing expression of the MFS efflux pump smvA. Here we show 
that loss of the regulator SmvR, through adaptation to chlorhexidine, results in increased resistance 
to a number of cationic biocides in K. pneumoniae and other members of the Enterobacteriaceae. 
Clinical Enterobacteriaceae isolates which lack smvA and smvR also have an increased susceptibility to 
chlorhexidine. When smvA from Salmonella and K. pneumoniae are expressed in Escherichia coli, which 
lacks a homologue to SmvAR, resistance to chlorhexidine increased (4-fold) but plasmid carriage of 
smvA alone was detrimental to the cell. Challenge of K. pneumoniae with chlorhexidine and another 
cationic biocide, octenidine, resulted in increased expression of smvA (approx. 70 fold). Adaptation to 
octenidine was achieved through mutating key residues in SmvA (A363V; Y391N) rather than abolishing 
the function of SmvR, as with chlorhexidine adaptation. Molecular modelling was able to predict that 
octenidine interacted more strongly with these mutated SmvA forms. These results show that SmvA is 
a major efflux pump for cationic biocides in several bacterial species and that increased efflux through 
SmvA can lead to increased chlorhexidine and octenidine tolerance.
With the rise in the number of infections caused by multi-drug resistant (MDR) pathogens, the pressure on 
antibiotic usage and infection prevention by other means has increased. This includes the use of biocides for 
disinfection of surfaces, medical devices and skin prior to operations. There is concern that the indiscriminate 
use of biocides is able to select for increased tolerance to particular biocides and also cross-resistance to antibi-
otics1–4. Indeed, overexpression of MDR efflux pumps such as acrAB-tolC in Escherichia coli5, mexCD-oprJ in 
Pseudomonas aeruginosa6 and smeDEF in Stenotrophomonas maltophilia7,8 has been linked to increased biocide 
tolerance.
The bisbiguanide chlorhexidine is widely used in clinical environments for many applications such as in 
mouth washes and wound dressings. Increased chlorhexidine susceptibility has been linked to deletion of a num-
ber of efflux pumps including aceI in Acinetobacter baumannii9 and cepA in Klebsiella pneumoniae10. Previously, 
we have shown that increased tolerance of chlorhexidine in K. pneumoniae is associated with increased expression 
of the efflux pump smvA through deletions in the adjacent divergently-transcribed gene termed smvR11.
SmvA was originally described as a chromosomally encoded major facilitator superfamily (MFS) efflux pump 
implicated in methyl-viologen efflux in Salmonella12,13. SmvR, like other TetR-like repressors is characterised by 
a HTH DNA binding domain14. The TetR family of regulators include AcrR, BetI and EnvR15,16, as well as those 
which have been implicated in biocide resistance, such as QacR from Staphylococcus aureus and AdeN from A. 
baumannii, which regulate the efflux pumps QacA and AdeIJK, respectively17,18. QacR has been shown to inter-
act with cationic compounds such as dequalinium, chlorhexidine and ethidium19,20 by utilising four glutamate 
residues lining the drug-binding interface to bind to the cationic compounds21. QacR regulates the expression of 
qacA and also its own expression by binding to specific palindromic repeats in the promoter region15,16.
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The aim of this study was to investigate the importance of SmvAR in tolerance to cationic biocides including 
chlorhexidine. To show this, we have examined whether K. pneumoniae strains, which have mutations in smvR, 
have decreased susceptibility to a range of cationic biocides, not just chlorhexidine. We also explored the impor-
tance of SmvAR in other Enterobacteriaceae (namely Citrobacter sp., Enterobacter sp. and Salmonella enterica 
serovar Typhimurium) in providing increased tolerance to chlorhexidine. We show that expression of smvAR in 
E. coli (an organism which appears to lack these genes) leads to decreased chlorhexidine susceptibility and that 
expression of smvA in K. pneumoniae is upregulated following chlorhexidine challenge. Computer modelling was 
employed to predict that chlorhexidine is able to bind to SmvA and identified specific residues that are theorised 
to be involved in the interaction of SmvA with chlorhexidine. Overall this demonstrated a clear role of SmvAR in 
mediating increased resistance to a range of cationic antiseptics.
Results
SmvA acts as a more general cationic biocide efflux pump in K. pneumoniae. We utilised transpo-
son mutants in smvA and smvR derived from the K. pneumoniae strain MKP10322 to understand more about the 
function of SmvAR and its relationship with biocide resistance. These transposon mutants had a T30 transposon 
(a derivative of Tn5 carrying a chloramphenicol resistance gene) inserted into either smvR or smvA. There were 
three transposon mutants in smvR (clones KP05926 (∆smvR1), KP05927 (∆smvR2), KP05928 (∆smvR3)) and a 
single transposon mutant in smvA (KP05925 (∆smvA)). All transposon mutants were whole genome sequenced 
and details of the position of transposon insertion are provided (Supplementary Table 1). MIC/MBCs were deter-
mined against a range of biocides (Table 1). For several cationic biocides, including chlorhexidine, CPC, CTAB, 
and cetrimide, the absence of SmvR led to a decrease in susceptibility (≥2-fold) relative to MKP103. For ∆smvA 
there was a 2-fold increase in susceptibility for chlorhexidine, cetrimide, CTAB and HDPCM. Transposon dis-
ruption of either smvR or smvA appeared to have no impact on antibiotic resistance for all antibiotics tested 
(Supplementary Table 2). However, MKP103 contains several antibiotic resistance markers including aminogly-
coside resistance genes (aadA2, aph(3′)-Ia, aac(6′)-Ib), fluoroquinolone resistance caused by mutations in GyrA 
(S83I) and ParC (S80I) as well as colistin resistance, which we hypothesise is caused by a previously undescribed 
mutation in PhoQ (Y265C). Therefore, it is plausible that any effects caused by loss of SmvA or SmvR function are 
masked by high level resistance mediated by pre-existing antibiotic resistance mechanisms.
Due to there being a modest difference (2–4 fold) in the MIC values for chlorhexidine of the transposon 
mutants relative to MKP103, MIC experiments were repeated but the OD600 was recorded every hour to gen-
erate a growth profile. For chlorhexidine, as the concentration of biocide increased the differences in growth 
rate between the mutants and the wild-type (MKP103) became more significant. The smvR transposon mutants 
reached maximal OD600 values more rapidly in the presence of increased concentrations of chlorhexidine, whilst 
∆smvA growth rate was retarded compared to MKP103 at the concentrations shown (Fig. 1).
SmvA is upregulated in response to chlorhexidine. Although we have recently shown that smvA is 
upregulated in mutants which have a non-functional SmvR11, we wanted to ascertain whether smvA transcript lev-
els are altered in direct response to chlorhexidine. Therefore, K. pneumoniae strain MGH 78578, which contains 
CHD MV BAC BEC CPC CTAB DDAB ALX DQC TRC ETH OCT CET HDPCM NaDCC VRK PAD H2O2 GLT
(A)
MKP103 64 >1024 32 64 8–16 64 16 2–4 256 2–4 6.25 4–8 0.004–0.007 16 125–250 0.5 0.04 0.005 0.39
∆smvA 16–32 >1024 32 64 8 64 16 4 256 2 6.25 4–8 0.002–0.004 8 250 0.5 0.04 0.01 0.39
∆smvR1 128–256 >1024 32 64 32 256 16 4 256 2 6.25 4 0.03 64 250 0.5 0.04 0.01 0.39
∆smvR2 128–256 >1024 32 32–64 64 256 16 4 256 2 6.25 4–8 0.03 64 250 0.5 0.04 0.005 0.39
∆smvR3 128–256 >1024 32 64 32 256 16 4 256 2 6.25 4–8 0.03 64 250 0.5 0.04 0.005 0.39
(B)
MKP103 64 >1024 32 64 8–16 64–128 16 4 >512 4 6.25 4–8 0.007–0.015 16 125–250 0.5 0.04 0.005 0.39
∆smvA 32 >1024 32 64 8 64 16 4 >512 2 6.25 8 0.002–0.004 8 250 0.5 0.04 0.01 0.39
∆smvR1 512 >1024 32 64 32–64 256 16 4 >512 4 6.25 8 0.03 64 250 0.5 0.04 0.01 0.39
∆smvR2 512 >1024 32 64 64–128 256 16 4 >512 2 6.25 8 0.03 64 250 0.5 0.04 0.01 0.39
∆smvR3 512 >1024 32 64 32–64 256 16 4 >512 2 6.25 8 0.03 64 250 0.5 0.04 0.005 0.39
Table 1. MIC (A) and MBC (B) values for smvA and smvR mutants compared to the wildtype MKP103. All 
values are in mg/L except for VRK (% Working concentration), CET, ETH, PAD, H2O2, GLT (all %) and NaDCC 
(ppm). Abbreviations used: chlorhexidine digluconate (CHD), methyl-viologen (MV), benzalkonium chloride 
(BAC), benzethonium chloride (BEC), cetylpyridinium chloride (CPC), cetyltrimethylammonium bromide 
(CTAB), didecyldimethylammonium bromide (DDAB), alexidine dihydrochloride (Alex), dequalinium 
chloride hydrate (DQC), Triclosan (TRC), ethanol (ETH), octenidine hydrochloride (OCT), cetrimide (CET), 
hexadecylpyridinium chloride monohydrate (HDPCM), sodium dichloroisocyanurate (NaDCC), virkon 
(VRK), peracetic acid (PAD), hydrogen peroxide (H2O2) and glutaraldehyde (GLT). All MIC/MBCs were 
performed in triplicate.
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full length smvA and smvR genes, was challenged with sub-MIC (8 mg/L) and lethal (128 mg/L) concentrations of 
chlorhexidine. The same strain was also challenged with sub-MIC (1 mg/L) and lethal (16 mg/L) concentrations of 
another cationic biocide, octenidine. This was because octenidine is increasingly used as a substitute for chlorhex-
idine and, unlike chlorhexidine, MIC/MBC values for octenidine for the smvA/smvR transposon mutants showed 
no change relative to MKP103. At the sub-MIC level for chlorhexidine, there was a significant upregulation of 
smvA (70-fold) and smvR (14-fold). At the lethal level there was upregulation of smvA (15-fold) and smvR (3.5 
fold). Perhaps surprisingly, given the lack of change in MICs following disruption to either smvR or smvA, after 
exposure to octenidine, there were similar levels of upregulation for both smvA and smvR as seen after challenge 
with chlorhexidine at both the sub-MIC and lethal concentrations (Supplementary Fig. S1).
Expression of smvA in E. coli increases tolerance to chlorhexidine. Blast searches revealed that E. 
coli contained no homologue for SmvAR and the majority of E. coli isolates tested had an MIC value of 0.5–1 mg/L 
to chlorhexidine (Supplementary Table 3), which is lower than Klebsiella (typically 16–32 mg/L) or other SmvAR 
containing members of the Enterobacteriaceae family tested. To test whether expression of smvAR from other 
Enterobacteriaceae would increase the resistance to chlorhexidine in E. coli, smvA and the smvAR region from K. 
pneumoniae MGH 78578 and Salmonella enterica serovar Typhimurium SL1344 were cloned into TOPO Vector 
pCR 2.1 and transformed into E. coli TOP10 (K-12) cells. Sequence analysis of several clones indicated that there 
were often mutations in the smvA sequence despite the original PCR product not showing any such mutations. 
Two clones, each containing either Salmonella smvA or smvAR or Klebsiella smvA or smvAR, were selected for 
further MIC testing, including, where possible, clones with no SNPs in smvA or smvR. All clones tested showed 
increased (4–8 fold) MIC values (2–4 mg/L) for chlorhexidine relative to plasmid only control (0.5 mg/L), but 
not for other cationic disinfectants tested (Fig. 2A). E. coli expressing Salmonella smvAR consistently gave 2-fold 
higher MIC values for chlorhexidine relative to clones expressing smvA alone. The growth of strains expressing K. 
pneumoniae, but especially for S. enterica smvA only, was also significantly reduced relative to SmvAR containing 
strains (Fig. 2B), potentially indicating that the expression of smvA without its regulator was more toxic to E. coli.
SmvR mutations are observed in other members of the Enterobacteriaceae upon chlorhexidine 
exposure and these also impact on cationic biocide resistance. Whilst mutations were observed in 
K. pneumoniae smvR following adaptation to chlorhexidine, we wanted to understand whether similar mutations 
were found in other members of the Enterobacteriaceae upon exposure to chlorhexidine. Therefore, strains of 
Klebsiella oxytoca, Citrobacter freundii, Enterobacter sp. and S. enterica, were exposed to increasing concentrations 
of chlorhexidine. Several K. pneumoniae strains were also adapted alongside as a control. Results showed that 
the Klebsiella species were most able to adapt, with 5/7 and 4/7 strains surviving in concentrations of 128 mg/L 
CHD for K. pneumoniae and K. oxytoca respectively. Mutations observed following chlorhexidine adaptation are 
described in Table 2. This shows the presence of additional K. pneumoniae mutations in smvR, along with several 
mutations in the smvAR promoter region, which had not been described in our previous study11. There were no 
mutations in PhoPQ identified as found previously11 but several strains had deletions in mgrB, the phoP regu-
lator gene. Mutations in mgrB were also found in K. oxytoca but no other strains showed genetic changes in the 
phoPQ controlled system. SmvR mutations were also found in Salmonella, C. freundii and K. oxytoca strains but 
not Enterobacter spp. Other mutations of interest include genetic changes in another TetR-family transcriptional 
Figure 1. Growth analysis of MKP103 ∆smvA and ∆smvR clones in the presence of chlorhexidine (CHD). 
Strains of K. pneumoniae were grown for 20 hrs (up to MIC measurement time) in different concentrations 
of chlorhexidine. The data presented are the means of four biological independent replicates. Significant 
differences in growth of MKP103 ∆smvA and MKP103 ∆smvR(1–3) relative to MKP103 are shown in the 
individual graph legends.
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regulator ramR, members from the BamABCDE complex involved in OM biogenesis e.g. bamE from Salmonella, 
and the MltA-interacting protein mipA. Mutations in mipA and bamD have been previously observed in K. pneu-
moniae11. For mutations in smvR, all mutations in non-Klebsiella species were found in the C-terminal ligand 
binding region; in Klebsiella mutations were either in the promoter or in the N-terminal DNA binding region. 
However, we have previously observed mutations throughout the gene (Fig. 3A)11. Therefore, adaptation to 
chlorhexidine thorough mutations in smvR is not exclusive to K. pneumoniae, but is observed in diverse mem-
bers of the Enterobacteriaceae. For those adapted strains from the other members of the Enterobacteriaceae 
with mutations in SmvR, there was an increase in tolerance to chlorhexidine and several other cationic biocides. 
This suggests that SmvA has a similar role in mediating tolerance to cationic biocides in several members of the 
Enterobacteriaceae.
Investigation of Klebsiella, Salmonella, Citrobacter and Enterobacter clinical strains from our collection, which 
had been whole genome sequenced, showed that a few strains lacked smvAR or had disrupted smvA genes. These 
strains showed reduced susceptibility to chlorhexidine and other cationic biocides (cetrimide, CPC, CTAB and 
HDPCM) (Table 3).
Further sequence analysis of the shared promoter region for smvAR revealed the presence of three palindro-
mic DYAD motifs which are typical for Tet-repressors and have been described for QacR15. In particular one 
palindromic motif (P3) was highly conserved between all species analysed (Fig. 3A). Indeed, SNPs in the smvAR 
promoter region, of Klebsiella strains after adaptation to chlorhexidine, affected the symmetry of palindromic 
sequence P3, which indicated that this is a likely SmvR binding site. Alignment of the 138 bp intergenic region 
for smvA and smvR for all K. pneumoniae strains in our database (approx. 90) showed that the sequence is highly 
conserved with most changes being sequence-type associated, although several strains have an affected palindro-
mic motif (P1) (Supplementary Fig. S2). These strains do not appear to have a noticeable change in chlorhexidine 
MIC, possibly indicating that P1 is not important for SmvR binding. There are sigma70 −35 and −10 regions 
predicted for smvR but not for smvA which may indicate that under normal conditions smvA expression may be 
downregulated. Analysis of the SmvR sequence from several members of the Enterobacteriaceae showed areas 
of conserved homology, in particular two areas highlighted in Fig. 3B and Supplementary Fig. S3, one in the 
predicted DNA binding N-terminal domain and one in the C-terminal substrate recognition domain which may 
indicate that similar substrates are recognised by the SmvR proteins from various different species.
Figure 2. Introduction of smvA into E. coli leads to increased resistance to chlorhexidine. MIC values to 
cationic biocides (A) and growth profiles (B) for E. coli expressing plasmids containing smvA or smvAR from 
S. enterica or K. pneumoniae. For E. coli clones KP indicates the fragment was cloned from K. pneumoniae and 
ST from S. enterica serovar Typhimurium. smvAR indicates that the fragment contains full length smvA and 
smvR including their promoters and smvA indicates that the fragment contains a full length smvA including its 
promoter. C2 indicates clone number 2 etc. Coding mutations found in various fragments are indicated. Control 
indicates plasmid only. Growth curves are the means of three independent repeats and statistical significance 
between clones and the control is shown where appropriate. All MIC values are given as mg/L except CET (%). 
For abbreviations see Table 1.
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Chlorhexidine is able to bind to SmvA through specific residues. To understand potential inter-
actions between SmvA and chlorhexidine, homology modelling and molecular docking studies were employed. 
These were able to show that theoretically chlorhexidine is able to interact with the central channel of SmvA 
(Fig. 4). A 100 ns molecular dynamics (MD) simulation provided information about the interaction of chlorhex-
idine with the binding pocket in SmvA. The complex remained stable during the course of the simulation largely 
due to the formation of hydrogen bonds and hydrophobic interactions with different residues. Hydrogen bond 
analysis showed that there are two permanent hydrogen bonds for SmvA-Chlorhexidine centred at residue Q392.
SmvA mutations occur in response to octenidine adaptation. Given the result that smvA was upreg-
ulated following exposure to octenidine, we sought to understand whether SmvA is also involved in the adaptive 
mechanism(s) associated with increased octenidine resistance. Strains of K. pneumoniae were adapted to octen-
idine in a similar manner to chlorhexidine. Several strains were able to survive in concentrations of 32–64 mg/L 
octenidine. When these were tested for increased MIC/MBC to octenidine there was only a two-fold increase 
for adapted strains compared to the parental strains (Table 4). There was also no noticeable cross-resistance to 
chlorhexidine or other cationic biocides. However, in general, these mutants again showed a significantly reduced 
doubling time, compared to their parental strains, in the presence of sub MIC-levels of either octenidine or chlor-
hexidine (Fig. 5), indicative of greater fitness under these conditions.
Analysis of the whole genome sequences for these adapted strains showed that they all contained a SNP in 
smvA with the majority (4/6 strains) containing a mutation which changed amino acid 363. The other muta-
tions which were found were L364Q and Y391N in one strain each. All these mutations likely affect the binding 
and positioning of the L364 and E392 residues, which were flagged as important for hydrogen bond formation 
in chlorhexidine binding (Fig. 4). Molecular docking of octenidine with the wild type SmvA and the A363V 
and Y319N mutants showed good binding energy −50.62, −49.43 and −47.77 kcal/mol respectively. However, 
the mutant A363V showed slightly better energy of binding (−49.43 kcal/mol) compared to Y319N mutant 
(−47.77 kcal/mol), and the A363V mutant complex also displayed better ChemScore value (48) compared to both 
wild type (45) and Y391N mutant (43). A 100 ns MD simulation was carried out to investigate the molecular level 
interactions within the dynamic system, and the post-MD simulation analysis showed superior relative binding 
free energy values for both mutant A363V (−58.65 kcal/mol) and Y319N (−57.84 kcal/mol) complexes compared 
to the wild type (−45.31 kcal/mol) complex (Table 5). The 2D interaction analysis of the complexes after the MD 
simulation highlighted notably stronger interactions, both electrostatic and hydrophobic, with the mutant A363V 
structure compared to the wild type structure (Fig. 6) and Y319N mutant (Supplementary Fig. S4), which sup-
ports the energy values obtained for the complexes. The energy values and interaction analysis suggest both wild 
type and mutant SmvA have a sufficient specificity and selectivity to octenidine that can form stable complexes 
with good energy of binding, which consequently could lead to transport of octenidine across the channel.





SNP in promoter ∆mgrB
SNP in promoter
6 Del nucleotides 48–54 RamR E7STOPWbaP Q386K
16 MgrB W20STOP SurA V32L
19 SNP H46D ∆mgrB
CFI_141-KPC WbaP D445E
K. oxytoca
7227 SNP in promoter CcmF F413V
7555 LpxM Del nucleotide 105 (truncated 37 aa protein)
5490 ∆mgrB Several genes around mgrB were also deleted.
CFI_80_KPC
RamR N56I
RamR 1 bp del (truncated 123 aa protein)
C. freundii
7556 OmpH Del nucleotide 270 (truncated 123 aa protein)







YebN insertion GGCTTCT after nucleotide 309
MipA insertion G after nucleotide 381
E. aerogenes CFI_16_OXA48 LptC G153R
S. enteritidis FW1401 Duplication aa 153–157 BamE W73STOP
S. arizonae FWE06 BamE Del nucleotide 47 (truncated 15 aa protein)
Table 2. Mutations observed after chlorhexidine adaptation in different members of the Enterobacteriaceae.
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Discussion
This study has shown that SmvA is an important efflux pump for chlorhexidine and other cationic biocides in 
K. pneumoniae and other members of the Enterobacteriaceae tested. This is also the first study to describe a 
potential resistance mechanism for K. pneumoniae to octenidine and suggests that adaptation to chlorhexidine 
and octenidine occurs through a common mechanism (SmvAR). With increasing use of antiseptics, particularly 
to help combat the spread of MDR infections, there has been a lack of surveillance to look for the prevalence of 
potential antiseptic resistance mechanisms23. We and others have shown that bacterial strains of K. pneumoniae 
and S. aureus isolated in the last few years have higher MIC values to chlorhexidine and octenidine than strains 
isolated before the widespread use of these antiseptics24,25. Therefore, it is possible that bacteria are becoming 
more tolerant to these antiseptics by mechanisms highlighted in this study.
The addition of smvAR from Salmonella and Klebsiella into E. coli increased tolerance to chlorhexidine; but 
when the regulator was not present, smvA was likely to be highly expressed and caused a growth defect in the 
cell. Mutations were often observed in smvA or its promoter, which are likely minimising the damaging effect of 
overexpressed smvA on cell growth. Overexpression of another native MFS pump in E. coli (mdtM) has also been 
shown to be energetically costly26. Klebsiella strains were able to tolerate high levels of smvA expression (above 
50-fold) in sub-MIC levels of chlorhexidine and those strains which had mutations in SmvR following chlorhex-
idine adaptation, generally had a constitutive 10–25 fold increase in smvA expression11. However, qPCR analysis 
in this study was performed after exposure to chlorhexidine for 20 mins and therefore the long-term effect of 
highly increased expression of smvA is unknown. Several adapted strains from a previous study were found to 
have additional mutations, such as those observed in PhoPQ, which may help to stabilise the membrane and com-
pensate for the increased levels of SmvA11. PhoPQ mutations were found to contribute towards colistin resistance, 
but on their own did not increase resistance to chlorhexidine11,27.
Mutations in palindromic repeats present in the promoter of smvA identified after chlorhexidine adaptation 
presumably affect the binding of SmvR to the smvA promoter, leading to overexpression of smvA. The E. coli efflux 
pump, MdfA, which is thought to efflux specific divalent cationic compounds like chlorhexidine, is naturally pres-
ent in a closed state and undergoes a conformation change upon binding of specific compounds28,29. Therefore, 
SmvA could also exist in two states, which depend on the presence of cationic compounds. Efflux systems may 
be recruited in response to environmental and external stress30 and the inactivation of the “stress response” in 
P. aeruginosa led to increased susceptibility to several antimicrobials31, highlighting its importance in antimi-
crobial resistance. We have yet to understand the main function of SmvA in K. pneumoniae and whether it is 
Figure 3. Sequence analysis for the smvA and smvR promoter region (A) and protein sequence for SmvR (B) 
between select members of the Enterobacteriaceae. Consensus sequences from K. pneumoniae (KP), K. oxytoca 
(KO), C. freundii (CF), E. cloacae complex (EC) and S. Typhimurium (ST) were aligned. Potential DYAD repeats 
in K. pneumoniae (P1 to P3) are indicated and mutations after CHD adaptation in K. pneumoniae are indicated 
in the gene and the promoter (bold italic). The −10 and −35 promoter regions are also indicated (underlined). 
(B) Highly conserved regions in the Enterobacteriaceae in the SmvR protein are indicated in boxes. One of 
the mutations (H46D) occurs in the N-terminal conserved region within the predicted DNA binding region. 
*indicates natural sequence variation in K. pneumoniae.
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specific for cationic compounds or part of a less-specific stress response. We also do not understand whether 
SmvR is able to respond to a variety of external stimuli and regulate multiple genes rather than just smvA. Several 
K. pneumoniae strains from the Murray collection, which were isolated before the widespread use of many cat-
ionic biocides, contain smvA genes with no sequence deviation from modern day clinical isolates24, suggesting 
Strain
Biocide MIC (mg/L) SmvAR status
CHD CET* OCT CPC CTAB HDPCM SmvA SmvR
Enterobacter
BS35 16 0.0039 4 32 32 16 WT C-terminal Extension
BS92 8 0.0009 2 8 16 16 WT WT
CFI_002_CRCN 2 ≤0.0005 2 8 8 8 Absent Absent
CFI_004_KPC 1 ≤0.0005 1 4 4 2 Disrupted WT
Salmonella
FWE 1401 8 0.0039 2 16 32 16 WT WT
FWE 1401 CHD 512 0.07 2 32 64 16 WT Insertion
Citrobacter
CK 51 2 0.0009 1 1 8 4 Disrupted WT
CK 54 2 0.0009 1 1 8 4 Disrupted WT
NCTC 9750 8 0.0009 2 2 8 8 WT WT
NCTC 9750 CHD 32 0.0019 2 2 16 8 WT Mutation
8 32 0.0039 2 2 32 16 WT WT
8 CHD 256 0.015 4 4 64 32 WT Transposon insertion
K. pneumoniae
BS26 8–16 ≤0.0005 4 4 8 4 Disrupted WT
M403 ≤0.5 ≤0.0005 2 4 8 1 Absent Absent
M635 ≤0.5 ≤0.0005 2 4 8 1 Absent Absent
M665 ≤0.5 ≤0.0005 2 2 4 2 Absent Absent
KP 115 1 0.0019 2 4 16 4 Absent Absent
6 32 0.0009 4 4 16 4 WT WT
6 CHD 128 0.007 4 64 128 64 WT Deletion
19 32 0.0018 4–8 16 32 16 WT WT
19 CHD 64 0.0018 8 16 32 16 WT Mutation
20 32 0.0009 8 4 8 4 WT WT
20 CHD 64 0.003 4–8 8 16 32 Mut in prom Mut in prom
K. oxytoca
0552 4 0.007 4 8 32 16 Absent Absent
7227 16 0.015 4 8 128 16 WT WT
7227 CHD 64 0.015 8 32 128 64 Mut in prom Mut in prom
Table 3. Variants in SmvAR and their effect on biocide tolerance. WT indicates that the sequence is full length. 
For list of abbreviations see Table 1. CHD indicates strains which have been adapted to chlorhexidine. *Value is 
given as %.
Figure 4. Molecular level interactions of chlorhexidine (CHD) within the binding pocket of K. pneumoniae 
SmvA. CHD showed hydrogen bond interactions with GLU392 and TYR10, and a range of hydrophobic 
interactions with LEU128, LEU364, ALA17 and TRP131.
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that this MFS pump has other naturally-occurring substrates. In Klebsiella, it is possible that multiple pumps 
are involved in the efflux of chlorhexidine. The finding of mutations in ramR, the indirect regulator of acrAB, 
in multiple strains after adaptation to chlorhexidine suggests a role for acrAB in chlorhexidine efflux. Other 
studies have indicated that specific pumps cepA and kpnGH are important in chlorhexidine efflux10,32. However, 
we have never observed mutations in either of these pumps following chlorhexidine adaptation and all strains of 
Enterobacteriaceae which lacked smvAR and were highly susceptible to chlorhexidine appeared to contain full 
length cepA and kpnGH equivalent genes.
Although we have yet to find clinical isolates of Klebsiella sp. with mutations in SmvR, we have recently iden-
tified a naturally occurring smvR deletion in Proteus mirabilis with elevated MICs for chlorhexidine (Pelling et 
al., manuscript in preparation). It is, however, clear that clinical isolates lacking smvAR are more susceptible 
to the action of cationic biocides. A homologue of smvA and its regulator has been found on a genomic island 
SmarGI1-1, containing the carbapenemase sme-2 in Serratia marcescens33, which can be transferred between 
Serratia strains34. This raises the possibility of transfer of SmvAR to other species, which may contribute to more 
widespread and increased chlorhexidine tolerance in clinical pathogens. Transfer of smvAR to different species 
Strain
Mutations after exposure MIC Level (mg/L)
SmvA Other CHD CET* OCT CPC CTAB HDPCM
NCTC 13443 w/t — — 16–32 0.0015 2 8 16–32 8
NCTC 13443 OCT SCV A363V
ArnA A504V
50S ribosomal protein L1 
Q80STOP
16 0.0015 4 8–16 32 8
NCTC 13443 OCT LCV L364Q 32 0.0015 4 8–16 16 8
NCTC 13438 w/t — — 16–32 0.0015 2 8 16–32 8
NCTC 13438 OCT A363V 16 0.0015 4 8 16 8
MGH 78578 w/t — — 16 0.0007–0.0015 2 8 8–16 8
MGH 78578 OCT Y391N 16–32 0.0015 4 8 8–16 8
M3 w/t — — 8 0.0003–0.0007 2 4 8 4–8
M3 OCT A363V WcaJ L33STOPNlpD L37Q 16 0.0007 4 4–8 8–16 8
NCTC 13439 — — 16–32 0.0015–0.003 2 16 16–32 16
NCTC 13439 OCT A363T SNP in promoter for sulA 16–32 0.003–0.007 4 16 16–32 16–32
Table 4. Mutations observed and MIC values for cationic biocides following octenidine adaptation in  
K. pneumoniae strains. w/t implies parental non-adapted strain and OCT means strain has been adapted to 
octenidine. *CET values are given as %. For abbreviations see Table 1.
Figure 5. Growth of octenidine adapted K. pneumoniae strains in sub-lethal levels of octenidine and 
chlorhexidine. Growth curves are the means of three independent repeats and the statistical significance in 
growth rate between octenidine adapted (OCT) and respective parental (w/t) strains is shown.
Complex MGH 78578 SmvA-OCT A363V SmvA-OCT Y391N SmvA-OCT
ΔEele 12.07 (9.32) 41.69 (12.25) −49.14 (7.77)
ΔEvdw −59.36 (2.62) −67.93 (2.12) −57.49 (2.40)
ΔEsur −9.72 (0.31) −10.18 (0.24) −8.29 (0.15)
ΔEsol 1.98 (10.46) −32.42 (10.42) 48.79 (7.98)
ΔGPB −45.31 (4.59) −58.65 (5.68) −57.84 (3.35)
ΔGGB −53.54 (2.78) −66.92 (3.06) −57.14 (2.48)
Table 5. Post-MD simulation average energy contributions (kcal/mol) observed for different OCT-SmvA 
complexes.
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and/or smvR deletion in clinical strains is therefore, likely to have a significant impact on bacterial resistance to 
multiple cationic biocides.
This study has highlighted the importance of the efflux pump SmvA in generating increased resistance to 
chlorhexidine, octenidine and other cationic biocides in Klebsiella and other Enterobacteriaceae. Increased smvA 
expression, whether as a response to chlorhexidine or octenidine exposure, or due to possible plasmid transfer, 
may cause a concern for the effectiveness of infection prevention procedures in the clinic. Monitoring smvAR 
mutations in clinical strains would provide an early warning of potential reductions in susceptibility to critical 
antiseptics, either directly by SmvA overproduction or in association with other resistance mechanisms.
Materials and Methods
Growth of bacterial strains and adaptation to biocides. All strains were grown in tryptic soy broth 
(TSB) with aeration or on tryptic soy agar at 37 °C unless otherwise stated. Transposon mutants from K. pneu-
moniae MKP103 have been described previously22. All transposon mutants were whole genome sequenced prior 
to use. Adaptation to biocides was carried out as described previously35 except that the starting concentrations 
were 4 mg/L chlorhexidine up to a final concentration of 128 mg/L. For octenidine the starting concentration was 
1 mg/L up to 64 mg/L.
Determination of MIC/MBC. Broth-Microdilution MIC analysis was performed as described previously36. 
All MIC’s were performed in TSB media using polystyrene 96 well plates (Corning, Flintshire, UK) except for the 
polymyxins, where polypropylene plates (Griener Bio-One Ltd, Stonehouse, UK) were utilised. Bacterial growth 
in the presence of biocides was measured by taking an OD600 reading every hour for 20 hours using a FLUOstar 
Omega plate reader (BMG Labtech GMBH, Ortenberg, Germany). For MBC testing, 10 µl of suspension was 
removed from each well of the MIC microtiter plate where no bacterial growth was observed, along with the two 
wells immediately below the MIC where growth was observed. These were spotted on TSA plates and incubated 
at 37 °C for 24 h. The MBC was defined as the lowest concentration of antibiotic/disinfectant at which no bacterial 
growth was observed in three replicate experiments.
Whole genome sequencing and Real Time-PCR. This was carried out as previously described11 and 
PHE Galaxy was used to analyse genetic changes37. Quantitative Real Time PCR was carried out and analysed as 
previously described using primers already described11. Exposure to chlorhexidine or octenidine was for 30 mins.
Cloning smvA(R) fragments into E. coli. K. pneumoniae and S. enterica serovar Typhimurium smvA and 
smvAR fragments were amplified from strains MGH 78578 and SL1344 respectively using primers described in 
Supplementary Table 4. Fragments were subsequently cloned into pCR 2.1 TOPO vector (Invitrogen) according 
to manufacturer’s instructions. Plasmids were then transformed into E. coli TOP10 cells and positive colonies 
selected for on TSA plates containing kanamycin (30 mg/L). Plasmid transformation was confirmed by PCR using 
Figure 6. Post-MD simulation 3D and 2D interaction analysis of wild type SmvA and mutant A363V SmvA 
complexes with octenidine.
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standard M13 forward and reverse primers. A selection of plasmids were purified and the smvA(R) fragment 
sequence confirmed by Sanger sequencing.
Homology modelling and generation of the SmvA Structures. The interaction of the wild-type 
SmvA efflux pump and its A363V and Y391N mutant forms in complex with different ligands was explored using 
computational methods including molecular docking, molecular dynamics (MD) simulation, molecular mechan-
ics, Poisson-Boltzmann surface area/molecular mechanics and generalised Born surface area (MM-PBSA/
MM-GBSA) calculation. Homology modelling was utilised for the generation of the structural model of the 
transporter in PDB format. The I-TASSER webserver38–40 was used for the homology modelling of SmvA struc-
tural model from K. pneumoniae, using the FASTA formatted target sequence with UniProt entry number of 
A6T9N7. C-score is a confidence score for estimating the quality of predicted models by I-TASSER, and a C-score 
of −1.08 was obtained for this model which is well within the acceptable range [−5, 2]. The generated model was 
without any gap, and all the segments were solved. Accelrys Discovery Studio 2017 was used to add probable 
missing side chains in the generated model. The mutant forms of SmvA were generated as A363V and Y391N 
individually, by the PyMOL program. The structures were minimised by the AMBER package program41,42 before 
carrying out the molecular docking and running MD simulations. Additional computational modelling methods 
are listed in supplementary methods.
Statistical analysis. All bacterial growth curves were analysed by calculating the time taken to reach half the 
maximal OD and then comparing these values with relevant controls using a Students Unpaired T-test. Real Time 
PCR data was analysed for significance using the Students Unpaired T-test. For significance P values < 0.0001 
****; 0.001–0.0001 ***; 0.01–0.001 **; 0.05–0.01 *; ≥0.05 non-significant were used.
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